Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Takeda’s dependence-free sleeping pill approved

September 2, 2005 Research and Development, Sales and Marketing

A new sleeping pill which patients cannot abuse or become dependent on has been approved in the US.Takeda's Rozerem (ramelteon) …
News

Pfizer acquires antibody optimisation company

August 17, 2005 Research and Development

Pfizer has purchased a company that develops technology to optimise antibodies to help it identify and develop new drugs with …
News

Acambis developing universal flu vaccine

August 17, 2005 Research and Development

Acambis has started developing a flu vaccine that could alter the market by offering permanent protection against influenza and guarding …
News

AstraZeneca’s Arimidex receives boost from study

August 11, 2005 Research and Development, Sales and Marketing

News

Quintiles acquires site management organisation Profiad

August 11, 2005 Research and Development

Contract research organisation Quintiles has acquired Profiad, a market-leading site management organisation, giving it access to the Reading-based firm clinical …
News

Increasing the appeal of science

August 10, 2005 Research and Development

UK science students rate pharmaceutical companies as ideal employers, according to a new survey.GlaxoSmithKline, AstraZeneca and Pfizer are all rated …
Feature

New study says cancer risk from HRT only moderate

August 10, 2005 Research and Development

The risk of developing breast cancer while on hormone replacement therapy may be lower than thought, according to a new …
News

Equity fund snaps up biotech Xenova for

August 9, 2005 Research and Development, Sales and Marketing

News

Personalising medicine

August 1, 2005 Research and Development

Hard times have hit the drug development industry. Faced with declining returns and the apparent waning of blockbusters, coupled with …
Feature

Iressa successor enters phase III

July 19, 2005 Research and Development, Sales and Marketing

AstraZeneca's oncology compound ZD6474 has entered phase III trials after positive results in trials in non-small cell lung cancer.The drug, …
News

AstraZeneca invests in novel cholesterol drugs

July 15, 2005 Research and Development

AstraZeneca is investing in a range of next generation cholesterol drugs which could reverse existing vascular disease in patients.The Anglo-Swedish …
News

Lilly buys rights to novel diabetes drug

July 6, 2005 Research and Development, Sales and Marketing

Eli Lilly has signed a licensing agreement with Japanese pharmaceutical company Taisho for TS-021, a novel treatment for type II …
News

Bright future for new antidepressants

June 30, 2005 Research and Development, Sales and Marketing

News

FDA approves first ‘ethnic’ heart drug

June 29, 2005 Research and Development, Sales and Marketing

The FDA has approved BiDil as a new treatment for heart failure in black patients, a group disproportionately affected by …
News

GSK sets up new R&D centre

June 1, 2005 Research and Development

GlaxoSmithKline has set up its eighth R&D Centre of Excellence which will focus on building partnerships with biotech firms, academia …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026